During a roughly five-year span, CVS Health, Cigna, and UnitedHealth benefited the most from increasing prices for generic drugs that treated illnesses such as HIV and cancer. Some of the price hikes ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
SEC sues Elon Musk over Twitter purchase, Microsoft says businesses should get quantum ready in 2025, and more news to start ...
The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...
The Sherwin-Williams Company is a resilient, well-established firm with a strong dividend history. Read why we rate SHW stock ...
The nation’s three largest PBMs – CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx – inflated ...
The practice inflated costs for consumers and insurers on key treatments for cancer, multiple sclerosis, HIV, organ transplants, and other conditions and procedures, the FTC said. The report ...
Pharmacies like Snyders rely on reimbursements to make ends meet. When his business dispenses prescriptions, the repayment ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity-drug maker tumbled after it slashed its projection for fourth-quarter revenue as the market for drugs that ...
Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback